Roadmap for research and care

Precision medicine is essential to the optimization of care for individual patients, but also in the efficient use of trials to develop new treatments much needed in psychiatry, Professor Arango (University Hospital Gregorio Marañón, Madrid, Spain) said during a State of the Art Lecture at EPA 2020.


Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

  1. Insel T, et al. American J Psychiatry 2010;167:748–751
  2. Fraguas D, et al. Schizophr Res 2012;137:58-65
  3. Lenze EJ, et al. JAMA Psychiatry 2020; March 25
  4. McGrath J, et al. Epidemiol Rev 2008;30:67-76  
  5. Fraguas D, et al. Psychol Med 2017; 47: 193–197
You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country